KBC Group’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$63K Hold
2,686
﹤0.01% 1559
2025
Q4
$38K Hold
2,686
﹤0.01% 1695
2025
Q3
$67K Hold
2,686
﹤0.01% 1508
2025
Q2
$61K Sell
2,686
-1,349
-33% -$32K ﹤0.01% 1491
2025
Q1
$122K Hold
4,035
﹤0.01% 1366
2024
Q4
$160K Buy
4,035
+1,347
+50% +$60.8K ﹤0.01% 1252
2024
Q3
$170K Buy
2,688
+338
+14% +$24.4K ﹤0.01% 1003
2024
Q2
$159K Buy
2,350
+346
+17% +$24.2K ﹤0.01% 943
2024
Q1
$159K Buy
2,004
+536
+37% +$43.8K ﹤0.01% 922
2023
Q4
$114K Hold
1,468
﹤0.01% 1003
2023
Q3
$103K Buy
+1,468
New +$110K ﹤0.01% 999

Other funds holding ACHC

KBC Group's ACHC Position: Q1 2026 in Review

KBC Group held its Acadia Healthcare (ACHC) position steady in Q1 2026 at 2,686 shares worth $63K. The position accounts for ﹤0.01% of the portfolio, ranked #1559.

KBC Group first reported a position in ACHC in Q3 2023 and has held it in 11 quarters since. The position peaked at $170K in Q3 2024. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • KBC Group held 2,686 shares of Acadia Healthcare worth $63K as of Q1 2026.
  • KBC Group left its Acadia Healthcare share count unchanged in Q1 2026.
  • Acadia Healthcare made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1559 holding.
  • KBC Group first reported a position in Acadia Healthcare in Q3 2023 and has held it in 11 quarters since.
  • KBC Group's Acadia Healthcare position peaked at $170K in Q3 2024.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.